4.Xinju Zhao, et al. Clinical Burden and Management of Hyperkalemia in Hemodialysis Centers in China: A Multicenter Retrospective Study (Visualize-HD). ASN Kidney Week 2023. Abstract TH-PO270. 审批编号 CN-124286 过期日...
2、Kanae Yoshikawa-Ryan, et al. Treatment Patterns and Clinical Events in Non-Dialysis-Dependent CKD Patients with Elevated C-Reactive Protein and Anemia: A Nationwide Hospital-Based Cohort Study in Japan. ASN Kidney Week 2023. Abstract TH-PO961. 3、Juyoung Jung, et al. Hemoglobin Variability ...
1. Abstract TH-PO1028, ASN 2023. 2. Abstract TH-PO358, ASN 2023. 3. Abstract TH-PO362, ASN 2023. 4. Zhou J, Jin X, Zhou J, et al. Clinical outcomes by serum potassium levels for patients hospitalized for heart failure: ...
参考文献 [1]Rosalba Y, et al. Limitations to the Use of Guideline-Directed Medical Therapy (GDMT) in Patients with CKD and Type 2 Diabetes Mellitus (DM) in the Primary Care Setting at an Inner-City Hospital in Bronx, New York. ASN Kidney Week 2023. SA-PO490 [2]Abstract TH-PO1028,...
文章链接参考:网页链接{AmericanSociety of Nephrology | Kidney Week - Abstract Details (2023)} Authors Xu, Lichen, Department of Nephrology and Nephrology Institute, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, Chi...
【2】Chen Jianghua,et al.Pegmolesatide for the Treatment of Anemia in Patients with CKD Undergoing Dialysis: Insights from a Randomized Active-Controlled Phase 3 Study. ASN 2024. ABSTRACT: TH-PO888 【3】American Society of Nephrology (ASN). https://www.asnonline.org/education/kidneyweek/ ...
培莫沙肽是一种新型长效聚乙二醇(PEG)化促红细胞生成素(EPO)模拟肽,于2023年6月获国家药品监督管理局(NMPA)批准上市,用于治疗因慢性肾脏病(CKD)引起的贫血【4】,并于当年纳入国家医保目录。既往Lancet子刊eClinicalMedicine发表过一项培莫沙肽针对CKD透析贫血患者的Ⅲ期临床研究1,这项随机、多中心、开放标签、非劣...
培莫沙肽是一种新型长效聚乙二醇(PEG)化促红细胞生成素(EPO)模拟肽,于2023年6月获国家药品监督管理局(NMPA)批准上市,用于治疗因慢性肾脏病(CKD)引起的贫血4,并于当年纳入国家医保目录。 既往Lancet子刊eClinicalMedicine发表过一项培莫沙肽针对CKD透析贫血患者的Ⅲ期临床研究1,这项随机、多中心、开放标签、非劣效性...
报告编号:TH-PO1123 (Abstract 3969868) 报告地址:Exhibit Halls B–D(宾夕法尼亚会议中心) 线上数据解读会信息: 英文会议: 会议时间:2023年11月3日,星期五,上午9时(北京时间) 注册链接:https://www.acecam...
报告编号：TH-PO1123 (Abstract 3969868)报告地址：Exhibit Halls B–D（宾夕法尼亚会议中心）线上数据解读会信息：英文会议： 会议时间：2023年11月3日，星期五，上午9时（北京时间）注册链接：参会者需要在电话会议之前进行注册。 会议直播链接：同时，参会者也可以使用以下拨入信息拨入电话会议：中文会议：会议...